Drug Type Synthetic peptide |
Synonyms Elcatonin (JP17/INN), HC 58, HC-58 + [7] |
Target |
Action inhibitors |
Mechanism CALCR inhibitors(Calcitonin receptor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (15 Jun 1982), |
RegulationOrphan Drug (United States) |
Molecular FormulaC148H244N42O47 |
InChIKeyDDPFHDCZUJFNAT-PZPWKVFESA-N |
CAS Registry60731-46-6 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Familial Paget's Disease of Bone | Japan | 07 Feb 2006 | |
Hypercalcemia | China | 22 Jun 1999 | |
Osteoporosis | Japan | 15 Jun 1982 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hemiplegia | Phase 2 | Japan | 01 Jul 2012 | |
Stroke | Phase 2 | Japan | 01 Jul 2012 |
Not Applicable | - | qyftfdmdba(mjvdumrqfe) = xcjlttulyu hayshmlnxh (abhcoqrdui ) | Negative | 23 Oct 2018 | |||
(Control Group) | qyftfdmdba(mjvdumrqfe) = lrpmktqdjc hayshmlnxh (abhcoqrdui ) |